Find insight on BCE, Siemens Healthineers, WeChat, Apple, U.S. tariffs and more in the latest Market Talks covering ...

AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.

The FTSE 100 finished up 103.99 at 8727.28 - a new record closing high. It also hit a new intraday record of 8,767.50 earlier ...

Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision, which it revealed ...

The boss of drugmaker AstraZeneca has said he was "very disappointed"” with the firm’s move to scrap plans for a £450 million vaccine plant in Liverpool, ...

The deal was signed with the Energize programme, a renewable energy purchasing vehicle for pharmeceutical companies.

Jobs are being slashed, investment has been cancelled and retail sales are stagnant, while consumer and business confidence have been shattered. Talk to anyone in industry, and it is clear the UK is ...

The boss of AstraZeneca Plc said he does not believe the UK is the worst place to invest, striking a conciliatory tone just ...

Lord Storey says he fears Merseyside was "not a high priority" on the government's growth agenda.

AstraZeneca Plc (NASDAQ:AZN) reported fourth-quarter sales of $14.89 billion, up 18% year over year (+19% at constant ...

AstraZeneca has halted plans to build a £450 million vaccine plant in the UK due to decreased government support, prompting ...

Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...